Vesnarinone

DB12082InvestigationalSmall molecule

Vesnarinone has been used in trials studying the treatment of HIV Infections and Sarcoma, Kaposi.

Chemical structure of Vesnarinone
Formula / weight
C22H25N3O4 · 395.4516 g/mol (avg)

Resolves to

Compound
UNII5COW40EV8MCAS81840-15-5ChEMBLCHEMBL17423ChEBI31237PubChem5663
Structure
InChIKeyZVNYJIZDIRKMBF-UHFFFAOYSA-NSMILESCOC1=C(OC)C=C(C=C1)C(=O)N1CCN(CC1)C1=CC=C2NC(=O)CCC2=C1
Targets
Q12809KCNH2Q14432PDE3A

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vesnarinone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In